BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3111991)

  • 1. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methimazole blocks Graves' IgG but not interferon-gamma HLA-DR expression by thyroid cells.
    Bodolay E; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1988 Jul; 18(3):167-71. PubMed ID: 3139552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
    Yoshikawa N; Mori S; Tokoro T; Ikehara S; Kumazawa H; Yamashita T; Nishikawa M; Inada M
    Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice.
    Kasuga Y; Matsubayashi S; Sakatsume Y; Miller N; Jamieson C; Volpé R
    J Endocrinol Invest; 1990 Dec; 13(11):871-8. PubMed ID: 2128634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
    Kasuga Y; Matsubayashi S; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1296-301. PubMed ID: 1902846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cellular interactions among thyrocytes, T cells and monocytes from patients with Graves' disease.
    Otsubo T; Eguchi K; Shimomura C; Ueki Y; Tezuka H; Ishikawa N; Ito K; Nagataki S
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):282-8. PubMed ID: 3132793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating HLA-DR (Ia) positive T cells and T cell activation by thyroglobulin, thyroid microsome and TSH-receptor in autoimmune thyroid diseases].
    Zeki K; Fujihira T; Shirakawa F; Watanabe K; Eto S
    Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):719-26. PubMed ID: 3499354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice.
    Yoshikawa N; Arreaza G; Mukuta T; Resetkova E; Miller N; Jamieson C; Nishikawa M; Inada M; Volpé R
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):31-9. PubMed ID: 7519528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do HLA-DR-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid drug treatment?
    Schleusener H; Schwander J; Holl G; Badenhoop K; Hensen J; Finke R; Schernthaner G; Mayr WR; Kotulla P
    Acta Endocrinol Suppl (Copenh); 1987; 281():318-24. PubMed ID: 2441554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy.
    Heufelder AE; Smith TJ; Gorman CA; Bahn RS
    J Clin Endocrinol Metab; 1991 Aug; 73(2):307-13. PubMed ID: 1906894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of HLA-DR3 and outcome after antithyroid drugs to the IgG subclass distribution of thyroid autoantibodies in Graves' disease.
    Weetman AP; Cohen SB
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):292-7. PubMed ID: 3493611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.